Compare WGS & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WGS | IART |
|---|---|---|
| Founded | 2017 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2020 | 1996 |
| Metric | WGS | IART |
|---|---|---|
| Price | $87.07 | $16.74 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 7 |
| Target Price | ★ $120.71 | $14.33 |
| AVG Volume (30 Days) | 750.4K | ★ 833.3K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.37 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $427,539,000.00 | N/A |
| Revenue This Year | $29.98 | $4.39 |
| Revenue Next Year | $25.92 | $3.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 39.97 | N/A |
| 52 Week Low | $32.21 | $8.70 |
| 52 Week High | $170.87 | $20.49 |
| Indicator | WGS | IART |
|---|---|---|
| Relative Strength Index (RSI) | 69.46 | 43.30 |
| Support Level | $81.55 | $16.04 |
| Resistance Level | $96.34 | $18.78 |
| Average True Range (ATR) | 5.31 | 0.64 |
| MACD | 0.70 | -0.10 |
| Stochastic Oscillator | 99.79 | 17.69 |
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.